Introduction & Market Context
Straumann Holding AG (SWX:SIX:STMN) presented its first quarter 2025 results on April 30, 2025, reporting solid organic growth despite varying regional performance. The dental solutions provider continues to expand its global footprint while investing in innovation and digital transformation to capture opportunities in an addressable market that has grown to approximately CHF 20 billion.
The company operates in a market with significant untapped potential, particularly in emerging economies where implant penetration remains low compared to developed markets. Straumann’s strategy focuses on portfolio diversification across price points and geographic regions, supported by a robust global supply chain.
Quarterly Performance Highlights
Straumann reported first quarter revenue of CHF 681 million, representing organic growth of 11.0% compared to the same period last year. While this growth rate is lower than the 17.5% achieved in Q1 2024, it remains in line with the company’s full-year guidance.
As shown in the following revenue development breakdown:
Starting from a Q1 2024 revenue base of CHF 618 million, the company experienced a negative foreign exchange impact of CHF 5 million. Organic growth contributed CHF 68 million to reach the final Q1 2025 revenue of CHF 681 million. The Asia Pacific region was the largest contributor to this growth at 45%, followed by EMEA at 38%, LATAM at 12%, and North America at just 5%.
The company highlighted several key achievements during the quarter, including the global rollout of Straumann AXS and iEXCEL product lines, as well as enhanced customer-centric solutions through the chairside workflow and collaboration with SprintRay.
Regional Performance Analysis
Straumann’s performance varied significantly across regions, with APAC and LATAM showing the strongest growth while North America lagged behind. The following regional breakdown illustrates these differences:
The APAC region delivered exceptional organic growth of 23.0%, though this represents a significant deceleration from the 82.0% growth recorded in Q1 2024. EMEA, which accounts for the largest share of group revenue at 41%, grew by 10.0%, slightly outpacing the 9.2% growth seen in the prior year period.
Latin America continued its strong performance with 18.8% organic growth, accelerating from 11.5% in Q1 2024. North America, representing 27% of group revenue, showed the weakest performance with just 1.8% organic growth, down from 3.7% in the same period last year.
Strategic Initiatives & Innovation
Straumann continues to focus on three strategic pillars: innovation, digitalization, and education. The company showcased its latest innovations at the International Dental Show (IDS), highlighting its expanding digital ecosystem centered around the Straumann AXS platform.
The following image illustrates Straumann’s comprehensive portfolio of innovative dental technologies:
A key strategic partnership announced during the quarter is the collaboration with SprintRay, which enhances Straumann’s chairside workflow capabilities. This integration into the digital AXS platform enables single-visit treatments, improving efficiency for dental practitioners.
To support its growth ambitions, Straumann is investing in expanding its global manufacturing footprint. The company highlighted progress on its Shanghai Campus and a new third factory in Brazil.
Market Opportunities & Growth Potential
Straumann estimates that its addressable market has grown to approximately CHF 20 billion globally, spanning implantology, regeneratives, clear aligners, and CAD/CAM equipment and prosthetics. The company currently holds a 12.5% share of this market, indicating significant room for expansion.
The following chart illustrates the market size and Straumann’s position across different segments:
A particularly compelling growth opportunity lies in markets with low implant penetration. As shown in the following chart, countries like Brazil, China, and India have significantly lower implant penetration rates compared to markets like South Korea and Spain:
Forward-Looking Statements
Straumann confirmed its outlook for 2025, projecting organic revenue growth in the high single-digit percentage range and a 30 to 60 basis points improvement in core EBIT margin at constant 2024 currency rates. The company also reaffirmed its 2030 growth ambitions.
Management acknowledged increased macroeconomic uncertainty but expressed confidence that the group’s globally diversified portfolio would continue to outgrow the market. The company’s capital allocation principles prioritize reinvesting in sustainable business growth, maintaining a strong balance sheet, pursuing strategic M&A opportunities, and maintaining and increasing dividends in line with earnings growth.
Straumann’s strategic roadmap and ongoing investments in innovation and global expansion position the company to capitalize on the significant growth potential in the dental solutions market, particularly in regions with low implant penetration rates. While growth in North America has slowed, strong performance in APAC and LATAM markets continues to drive overall organic growth.
Full presentation:
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.